Coffee consumption and liver-related hospitalizations and deaths in the ARIC study.
Coffee consumption and liver-related hospitalizations and deaths in the ARIC study.
复制标题
ARIC研究中的咖啡消费和与肝有关的住院和死亡。
DOI:
10.1038/s41430-018-0346-0
复制
发表时间:
2019-08
影响因子:
4.7
通讯作者:
Rebholz CM
中科院分区:
文献类型:
--
作者:
Hu EA;Lazo M;Selvin E;Hamilton JP;Grams ME;Steffen LM;Coresh J;Rebholz CM
Coffee consumption has been found to be associated with reduced risk of chronic conditions such as liver disease. However, less is known about the association between coffee and liver-related hospitalizations and deaths. We conducted a prospective analysis on 14,208 participants aged 45–64 years from the Atherosclerosis Risk in Communities (ARIC) study. Coffee consumption (cups/day) was assessed using food frequency questionnaires at visit 1 (1987–89) and visit 3 (1993–95). Liver-related hospitalizations were defined as a hospitalization with any International Classification of Diseases, Ninth Revision (ICD-9) code related to liver disease identified through cohort surveillance. Liver-related death was defined as any death with a liver disease ICD-9 code listed anywhere on the death certificate form. There were 833 incident cases of liver-related hospitalizations over a median follow-up of 24 years and 152 liver-related deaths over a median follow-up of 25 years. Participants who were in the highest category of coffee consumption (≥3 cups/day) were more likely to be men, whites, current smokers, and current alcohol drinkers. In our fully adjusted model, consuming ≥3 cups/day of coffee was significantly associated with a reduced risk of liver-related hospitalizations compared with never drinkers (hazard ratio: 0.79, 95% CI: 0.63–0.99). There were no significant associations between coffee consumption and liver-related deaths after adjusting for covariates. Coffee drinkers may be at lower risk for liver-related hospitalizations. This supports current evidence that low and moderate levels of coffee may be protective to the liver.
登录
查看更多内容
DOI:
10.1056/nejmoa1112010
发表时间:
2012-05-17
期刊:
The New England journal of medicine
影响因子:
--
作者:
Freedman ND;Park Y;Abnet CC;Hollenbeck AR;Sinha R
通讯作者:
Sinha R
影响因子:
13.5
作者:
Xiao, Qian;Sinha, Rashmi;Graubard, Barry I.;Freedman, Neal D.
通讯作者:
Freedman, Neal D.
影响因子:
39.2
作者:
Park SY;Freedman ND;Haiman CA;Le Marchand L;Wilkens LR;Setiawan VW
通讯作者:
Setiawan VW
影响因子:
12.6
作者:
Bravi, Francesca;Bosetti, Cristina;La Vecchia, Carlo
通讯作者:
La Vecchia, Carlo
DOI:
10.1053/j.ajkd.2016.05.019
发表时间:
2016-12
期刊:
American journal of kidney diseases : the official journal of the National Kidney Foundation
影响因子:
--
作者:
Rebholz CM;Crews DC;Grams ME;Steffen LM;Levey AS;Miller ER 3rd;Appel LJ;Coresh J
通讯作者:
Coresh J